Literature DB >> 21507928

Pharmacokinetics of polymyxin B in a patient with renal insufficiency: a case report.

Andrea L H Kwa, Kamilia Abdelraouf, Jenny G H Low, Vincent H Tam.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21507928      PMCID： PMC3115279          DOI： 10.1093/cid/cir137

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

Review 1.  Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.

Authors:  M E Evans; D J Feola; R P Rapp
Journal:  Ann Pharmacother       Date:  1999-09       Impact factor: 3.154

Review 2.  Polymyxin B: similarities to and differences from colistin (polymyxin E).

Authors:  Andrea Kwa; Sofia K Kasiakou; Vincent H Tam; Matthew E Falagas
Journal:  Expert Rev Anti Infect Ther       Date:  2007-10       Impact factor: 5.091

3.  Comment on: Development and validation of a reversed-phase high-performance liquid chromatography assay for polymyxin B in human plasma.

Authors:  Vincent H Tam; Jingguo Hou; Andrea L Kwa; Randall A Prince
Journal:  J Antimicrob Chemother       Date:  2008-11-19       Impact factor: 5.790

4.  Variability of polymyxin B major components in commercial formulations.

Authors:  Jie He; Kimberly R Ledesma; Wai-Ying Lam; Deborah A Figueroa; Tze-Peng Lim; Diana S-L Chow; Vincent H Tam
Journal:  Int J Antimicrob Agents       Date:  2009-12-31       Impact factor: 5.283

5.  Pharmacokinetics of polymyxin B1 in patients with multidrug-resistant Gram-negative bacterial infections.

Authors:  Andrea L H Kwa; Tze-Peng Lim; Jenny G H Low; JingGuo Hou; Asok Kurup; Randall A Prince; Vincent H Tam
Journal:  Diagn Microbiol Infect Dis       Date:  2007-10-04       Impact factor: 2.803

6.  Pharmacokinetics of intravenous polymyxin B in critically ill patients.

Authors:  Alexandre P Zavascki; Luciano Z Goldani; Guoying Cao; Silvana V Superti; Larissa Lutz; Afonso L Barth; Fabiano Ramos; Márcio M Boniatti; Roger L Nation; Jian Li
Journal:  Clin Infect Dis       Date:  2008-11-15       Impact factor: 9.079
  6 in total
  18 in total

1.  Population Pharmacokinetics of Intravenous Polymyxin B from Clinical Samples.

Authors:  Christine J Kubin; Brian C Nelson; Cristina Miglis; Marc H Scheetz; Nathaniel J Rhodes; Sean N Avedissian; Serge Cremers; Michael T Yin
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Dose adjustment of polymyxins for renal insufficiency.

Authors:  Alexandre P Zavascki
Journal:  Antimicrob Agents Chemother       Date:  2011-10       Impact factor: 5.191

3.  Critical Need for Clarity in Polymyxin B Dosing.

Authors:  Nikolas J Onufrak; Gauri G Rao; Alan Forrest; Jason M Pogue; Marc H Scheetz; Roger L Nation; Jian Li; Keith S Kaye
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

Review 4.  Colistin and polymyxin B: peas in a pod, or chalk and cheese?

Authors:  Roger L Nation; Tony Velkov; Jian Li
Journal:  Clin Infect Dis       Date:  2014-04-03       Impact factor: 9.079

5.  Influence of rhlR and lasR on Polymyxin Pharmacodynamics in Pseudomonas aeruginosa and Implications for Quorum Sensing Inhibition with Azithromycin.

Authors:  Zackery P Bulman; Neang S Ly; Justin R Lenhard; Patricia N Holden; Jürgen B Bulitta; Brian T Tsuji
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

6.  Dosing and Pharmacokinetics of Polymyxin B in Patients with Renal Insufficiency.

Authors:  Visanu Thamlikitkul; Yanina Dubrovskaya; Pooja Manchandani; Thundon Ngamprasertchai; Adhiratha Boonyasiri; Jessica T Babic; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2016-12-27       Impact factor: 5.191

7.  Risk factors for treatment failure of polymyxin B monotherapy for carbapenem-resistant Klebsiella pneumoniae infections.

Authors:  Yanina Dubrovskaya; Ting-Yi Chen; Marco R Scipione; Diana Esaian; Michael S Phillips; John Papadopoulos; Sapna A Mehta
Journal:  Antimicrob Agents Chemother       Date:  2013-08-19       Impact factor: 5.191

8.  Pharmacokinetics and renal disposition of polymyxin B in an animal model.

Authors:  Kamilia Abdelraouf; Jie He; Kimberly R Ledesma; Ming Hu; Vincent H Tam
Journal:  Antimicrob Agents Chemother       Date:  2012-08-20       Impact factor: 5.191

Review 9.  Rescuing the Last-Line Polymyxins: Achievements and Challenges.

Authors:  Sue C Nang; Mohammad A K Azad; Tony Velkov; Qi Tony Zhou; Jian Li
Journal:  Pharmacol Rev       Date:  2021-04       Impact factor: 25.468

10.  Paradoxical Effect of Polymyxin B: High Drug Exposure Amplifies Resistance in Acinetobacter baumannii.

Authors:  Brian T Tsuji; Cornelia B Landersdorfer; Justin R Lenhard; Soon-Ee Cheah; Visanu Thamlikitkul; Gauri G Rao; Patricia N Holden; Alan Forrest; Jürgen B Bulitta; Roger L Nation; Jian Li
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.